CIK 0000887359 · Large accelerated filer
Vericel Corp
Sign in to watch- Ticker
- VCEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- MI
- Entity type
- operating
- EIN
- 943096597
- Phone
- 6175885555
- Business address
- 25 BLUE SKY DRIVE, BURLINGTON, MA, 01803
- Former names
- AASTROM BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,787,802
- in 7 filings, $5.8M under 10b5-1 plans
Net −$5,787,802. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Mara Joseph Anthony Jr −$4.1M Chief Financial Officer sold 82% of stake
- Flynn Sean C. −$779K Chief Legal Officer sold 88% of stake
- MCLAUGHLIN KEVIN F −$413K Director sold 28% of stake
- ZERBE ROBERT L MD −$386K Director sold 19% of stake
- SIEGAL JONATHAN −$79K Principal Accounting Officer sold 54% of stake
Reading 65 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-19 | Hopper Jonathan Mark Chief Medical Officer | Option exercise · Restricted Stock Unit | −1,750 | $34.90 | $61K | 5,250 |
| 2022-02-19 | Halpin Michael Chief Operating Officer | Option exercise | +2,812 | 11,495 | ||
| 2022-02-19 | Halpin Michael Chief Operating Officer | Shares withheld for taxes | −1,248 | $34.90 | $44K | 10,247 |
| 2022-02-19 | Halpin Michael Chief Operating Officer | Option exercise · Restricted Stock Unit | −2,812 | $34.90 | $98K | 8,438 |
| 2022-02-19 | Flynn Sean C. VP, General Counsel | Option exercise | +1,750 | 4,314 | ||
| 2022-02-19 | Flynn Sean C. VP, General Counsel | Shares withheld for taxes | −869 | $34.90 | $30K | 3,445 |
| 2022-02-19 | Flynn Sean C. VP, General Counsel | Option exercise · Restricted Stock Unit | −1,750 | $34.90 | $61K | 5,250 |
| 2022-02-19 | Colangelo Dominick President and CEO | Option exercise | +8,937 | 160,307 | ||
| 2022-02-19 | Colangelo Dominick President and CEO | Shares withheld for taxes | −3,875 | $34.90 | $135K | 156,432 |
| 2022-02-19 | Colangelo Dominick President and CEO | Option exercise · Restricted Stock Unit | −8,937 | $34.90 | $312K | 26,813 |
| 2022-02-18 | SIEGAL JONATHAN Principal Accounting Officer | Grant or award · Stock Option (right to buy) | +4,198 | 4,198 | ||
| 2022-02-18 | SIEGAL JONATHAN Principal Accounting Officer | Grant or award · Restricted Stock Unit | +1,679 | 1,679 | ||
| 2022-02-18 | Hopper Jonathan Mark Chief Medical Officer | Grant or award · Stock Option (right to buy) | +51,385 | 51,385 | ||
| 2022-02-18 | Hopper Jonathan Mark Chief Medical Officer | Grant or award · Restricted Stock Unit | +9,300 | 9,300 | ||
| 2022-02-18 | Hopper Jonathan Mark Chief Medical Officer | Grant or award · Stock Option (right to buy) | +2,865 | 2,865 | ||
| 2022-02-18 | Halpin Michael Chief Operating Officer | Grant or award · Stock Option (right to buy) | +2,865 | 2,865 | ||
| 2022-02-18 | Halpin Michael Chief Operating Officer | Grant or award · Stock Option (right to buy) | +86,385 | 86,385 | ||
| 2022-02-18 | Halpin Michael Chief Operating Officer | Grant or award · Restricted Stock Unit | +15,300 | 15,300 | ||
| 2022-02-18 | Flynn Sean C. VP, General Counsel | Grant or award · Stock Option (right to buy) | +51,385 | 51,385 | ||
| 2022-02-18 | Flynn Sean C. VP, General Counsel | Grant or award · Restricted Stock Unit | +9,300 | 9,300 |
Page 43 of 75 · 1,497 trades